You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

Article info

Article menu
XML
Immunotherapy biomarkers
Original research
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

Authors

  • Jennifer L Marté Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Nicole J Toney Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Lisa Cordes Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Jeffrey Schlom Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Renee N Donahue Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • James L Gulley Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr James L Gulley; gulleyj{at}mail.nih.gov
View Full Text

Citation

Marté JL, Toney NJ, Cordes L, et al
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management
Journal for ImmunoTherapy of Cancer 2020;8:e001019. doi: 10.1136/jitc-2020-001019

Publication history

  • Accepted November 5, 2020
  • First published November 20, 2020.
Online issue publication 
November 20, 2020

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.